Tag Archives: direct-acting anti-viral agent

Are Patients Receiving the Latest Anti-HCV Drugs?

Posted on July 22, 2013 by Kristine Novak, PhD, Science Editor

Less than 20% of patients infected with the most common Hepatitis C virus (HCV) genotype receive the latest drugs approved by the US Food and Drug Administration (FDA), according to the August issue of Clinical Gastroenterology and Hepatology. This low … Continue reading →

Posted in Liver/Biliary, Technology | Tagged , , , , , , , , , , , , | 2 Comments